A study based on analysis of clinical samples and melanoma cells from male and female patients showed that genetic and pharmacological suppression of AR activity triggers melanoma cell senescence and limits tumorigenesis, while increased AR expression or activation exert opposite effects. Here, AR is linked to melanoma.